The intersection of TB and diabetes mellitus (DM) represents a pressing global health concern that demands urgent attention. DM is a well-established risk factor for TB, increasing susceptibility to the disease and worsening treatment outcomes. Compounding this, TB patients with uncontrolled hyperglycaemia — whether due to pre-existing DM or TB-induced stress hyperglycaemia — face a higher risk of poor TB outcomes. In response, the WHO has recommended diabetes screening for TB patients since 2011.
A commentary, published in BMJ Global Health, highlights the need for a novel clinical concept: tuberculous hyperglycaemia. ‘Tuberculous hyperglycaemia’ parallels the concept of gestational diabetes, which is hyperglycaemia during pregnancy. Similarly, tuberculous hyperglycaemia describes hyperglycaemia caused by TB, which typically resolves on successful TB treatment. This paradigm shift could enhance TB care, improve outcomes and advance the integration of TB and DM management worldwide.
Access the full commentary here.
For more TB updates, check out the TB CAB Weekly Newsletter (Issue #38, 12 December 2025).
The newsletter is brought to you by the Global TB Community Advisory Board (TB CAB) with the support of Treatment Action Group (TAG) and the European AIDS Treatment Group (EATG). Subscribe to the newsletter here.
Source : BMJ Global Health
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.